177Lu-TR0471

N/A

Report date: 2025/11/21 17:16:29

NME

Base Information

Drug Name177Lu-TR0471

Drug Alias Name177Lu-TR0471177LuTR0471

ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177Lu +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesC-Ray Therapeutics (Chengdu) Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesC-Ray Therapeutics (Chengdu) Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms, Castration-Resistant

Inactive IndicationsN/A

Other Information

ATC CodeN/A